The estimation of competitive positions of non-steroid anti-inflammatory drugs on pharmaceutical ... The offered model of estimation of competitiveness of the studied group of medicines is based on the construction of competition map of medicines, on the example of nonselective NSAID as the largest group by the number of presented trade names (TN), using the calculation of market share of NSAID for 2015-2016 and the dynamics of its growth. The first stage includes the analysis of assortment and determination of modern tendencies of NSAID market formation. It is necessary to note that the methodological base of estimation of competitive positions in the market share. That is why, the second stage provides the estimation of competitive situation on NSAID market, realized by calculation of the market share of each formulation of the presented TN of studied segment of medicines. Thus, the calculation of market share for each NSAID TN was carried out according to the formula 1 (Berman &Telen,2004) :
T D % T =´ (1) where, D -market share of і-th TN NSAID, % T i -sales volume for і-th TN NSAID in DDDs sold per year T gen. -general volume of NSAID sales in DDDs sold per year.
Depending on the volume of market share, medicines can be leader or outsider in the market. To differentiate the groups of medicines − outsiders, medicines with weak, strong competitive position and leaders of the market., within the third stage, it is necessary to determine the mean-square deviation of NSAID TN market share and also its minimal, maximal and mean arithmetical value. Thus, we realized the determination of limits of classification groups of studied NSAID using the law of variation of individual values of sign ('three-sigma rule'). The directions of fourth stage of methodology that are the estimation of NSAID competitive positions provide determination of dynamics of growth, mean value and dispersion of dynamics of growth of NSAID TN market share. Thus, the calculation of mean dynamics of the market share growth for each formulation of medicines TN for the studied period (2016) relative to the base period (2015) and its meansquare deviation was realized according to the formula 2 (Burtseva et al. 
RESULTS
At the first stage of the offered methodology, according to the results of the data of Public register of medicines, which includes all medicines approved for marketing by the Ministry of Health of Ukraine, it was established that NSAID assortment is presented by 13 pharmacotherapeutic groups:
-mefenamic acid (Ministry of Health of Ukraine, 2015) . The analysis at the second stage included 74 TNs of medicines, divided into 2 sectors in correspondence with the occupied share. The first sector included medicines, for which the market share was more than the mean arithmetic value of market shares of the studied NSAID; the other one united medicines, for which the market share was less than the mean arithmetic value (1.35%). Thus, the first sector was formed of 18 NSAID TNs with mean volume of market share 4.51%, and other 56 TNs with mean volume of market share 0.34%. Within the third stage, the calculations of mean-square deviation of NSAID TN market share, that in totality with minimal and maximal values allows us to make distribution of the studied medicines in 4 classification groups, were realized in each sector (Table1).
The results of NSAID TN distribution in groups according to the market share volume testify that only 8 TNs of medicines among 74 are the leaders of market and 10 TNs are characterized with strong competitive position. At the same time, 51 NSAID TNs are outsiders and 5 TNs have weak competitive positions. It is well-known that the estimation of tendencies of change of competitive position is realized using the index of mean dynamics of market share growth. Thus, the calculated mean dynamics of growth of the studied NSAID segment is 21.91% (the fourth stage of methodology). NSAID TN classification by the degree of change of competitive position is presented in Table 2 The estimation of competitive positions of non-steroid anti-inflammatory drugs on pharmaceutical ... 
DIScUSSION
In modern practice of applied marketing research, considerable attention is paid to the analysis of market environment. The study of market processes involves determining the dynamics of market conditions. Each company faces the task of assessing its own competitiveness, which is due to the quality management of supply processes. The most important for enterprises are the indicators that reflect the dynamics of consumption of goods, the volume of wholesale and retail trade. Also, in the conditions of limited information for manufacturers, it is relevant to calculate the capacity and market share, to assess the level of competitiveness of products.
The results of the conducted research provide comprehensive and reliable information on both the dynamics of pharmaceutical market and trends in its structural segments, trademarks. Using the obtained results, the manufacturing companies are able to monitor market conditions, its capacity and development trends. Also, it is possible to conduct market segmentation by commodity and market characteristics to conduct their comparative analysis. Searching market niches and choice of perspective directions of optimization of commercial policy; conducting competitive analysis and establishing market segments with the lowest competitive activity becomes more reasonable and appropriate. Thus, the competitive map of medicines serves to determine their status and to systematize their competitive advantages. In 2016, in the Ukrainian market of NSAIDs, there is a situation where there are no TN-leaders of market and TN that pretend to leadership with rapid improvement of the competitive position.
The offered methodology of estimation of NSAID competitive positions, from our point of view, can be used by pharmaceutical enterprises for choosing the grounded approaches to elaboration of competitive strategy, preventing the negative tendencies in production-selling processes of enterprises. The received results that are the real reproduction of the modern market situation, allow enterprises to determine the features of development of competitive situation on the market and to reveal the closest competitors. For manufacturers of medicines-leaders of market, according to the market share, the main directions of competition strategies are the stabilization of competitive position by maintaining the achieved level of profitability and by creating a more flexible pricing policy. In order to achieve competitiveness, the following strategic alternatives are recommended for the manufacturers of medicines with a strong competitive position: search for a vacant niche with weak competition, adapting to the selected target market, following the behaviour of the leader. Manufacturers of medicines with weak competitive position must focus on reducing the cost of medicines. The position of medicines-outsiders of the investigated segment of the market requires pharmaceutical companies to reorganize their marketing strategies (with a significant reduction in costs or, conversely, an increase in the medicine prices in the case of inelastic demand).
LIMITATIONS OF RESEARcH
Market researches on the competitiveness in pharmacy on various thematic areas of competitive analysis are widely represented in the scientific works of Ukrainian scientists.
But detailed analysis of publications shows that mainly the competitiveness of manufacturing companies, pharmacies and limited analysis of the competitive advantages of medicines were investigated. At the same time, the lack of available state statistical information on sales volumes makes it impossible to carry out a full-fledged analysis of the market situation in the domestic pharmaceutical market, which determines the use of special methods of calculation and additional sources of information. The additional sources of information include data on the Thus, the obtained results are a real reproduction of the current market situation and allow developing a competition strategy more reasonably, to avoid or prevent the negative trends in the production and sales processes of the enterprises. Taking into account the obtained results, enterprises have the opportunity to operate information about the competitive status, to know the features of the development of a competitive situation on the market and to identify the closest competitors.
